* Required information |
Phase |
| |||
|---|---|---|---|---|
Status |
| |||
Start Date | Enter the starting date of your initiative, by clicking on the calendar icon bellow - when you started to work on different step of the initiative
| |||
Initiative name ID Provided by DT PMO | Prometheus - M&A integration | |||
Description of the initiative | Prometheus is an M&A Acquisition (R&I - Biomatech platform / SCO perimeter) part of a partnership established between Solvay and Ginkgo Bioworks (see press release). Solvay acquires a Ginkgo (formerly Zymergen) laboratory in Cambridge, Massachusetts. This acquisition will expand Solvay’s R&I footprint in the US, provide access to new talents, and establish a sustainable growth base in synthetic biology in one the most important biotech hubs in the world, accelerating the company’s biotech development plan. The initiative consists of the main activities listed beow:
As signing and closing of the deal were performed at the same date with quite no time to prepare the integration, a 2-step initiative is proposed with a full implementation not exceeding 1M€:
| |||
Domain & Product | ||||
Requested Domain Journey / Platform |
| |||
| Involved Domain Journey/ Platform |
| |||
Initiative Ownership | ||||
Digital Technology Partner | Enter the Digital Technology Partner, using « @ » for user attribution (if not known refer to the DT Playbook in "Relation with GBU & BSA" chapter) @ | |||
Product Manager / Service Delivery | Patrick Vignon + ISSANCHOU, Sebastien / Julie Mijajlovic @Mark Kwasnik | |||
Roadmap & Key objectives | ||||
Roadmap | ||||
2023 Digital Technology Key objective | ||||
Priority | P1 Must do | |||
Understand: Why is this initiative proposed? What are the consequences if not done? What are the new capabilities expected?
|
|
* Why is this initiative proposed today?
Explain what are the motivations and the expected objective behind this initiative/ what are the consequences if not done?
| This initiative supports an R&I acquisition for new BioTech division within Solvay. Integration of this new site into Solvay standards will help to maximize Solvay's investment in this site and new technology |
What are the new capabilities expected?
| New Biotech and technology site in Cambridge, MA to be incorporated into Solvay standards for R&I. |
What will it replace? Is it a new solution or an existing one?
| New R&I location |
Who are the future users?
Identify the future users (BU, sites...) and population concerned
| Existing R&I scientists at the site |
What is the number of users impacted?
| Currently there are 3 research scientists. This figure is likely to expand to 25 FTEs in the next years |
What about the Business Needs?
What is the value of the initiative?
Financial Business expectation (ROI, benefits, savings,...) + Qualitative Business expectation (business value, market fit, visibility,...)
| Overall investment estimated at 965k€ max to ensure business continuity and to implement Solvay standards to allow Solvay to take advantage of the initial investment in the Biotech industry. |
How does the product / deliverable align with the business goals?
| Allows Solvay to move into BioTech, integration of the site into Solvay standards provides security for investment. |
Are there any challenges in developing the product?
| No TSA for this purchase. Timing for the move to another floor within the existing building. Project implementation must be done by October 2023. |
How will we measure success?
| By end of May collect and organize cost information from the strategize performed in April/May to present to the PMO for validation. New Solvay site in Cambridge successfully moves to the new floor by October 2023 with Solvay standards in place. |
Please duplicate this template and contact the SIP team in order to get your corresponding folder. Then, for the envision phase, answer to the initiative card tab and to the 7 high-level questions in the "Security Scoring" tab. These questions will help the SIP team to determine the level of cybersecurity & compliance support you will need. Please contact the team by email: @SIP_team@solvay.com
If not able to answer yet, explain it at the Envision gate and it will be the DTLT to decide if green light or not considering with the high level of uncertainty
An initial security audit has been performed and shared with the security team. As per feedback from the SIP team, "The outcome of our discussion is that the SIP Tool won't be needed for this project. Joao will follow your project in order to check that Solvay standards are applied along the later". |
If your initiative is working with data, please select the domain which is impacted:
Estimated Delivery phase start date*
| Estimated Delivered end Quarter* Q4 2023 |
What is the coherent money to commit on the initiative?*
| 2023 (in K€)* | 2024 (in K€)* | 2025 (in K€) | |
|---|---|---|---|
Estimated size of investment (high level) | 965 | 0 | 0 |
What is the coherent run and build commit on the initiative?
Only run cost impact - TCO over 10Y will be finalized during the strategize phaseEstimated run costs (estimation high level) per year on xxYear (xx= duration of the contract if known) ~120K€ | Type of savings expected /year for DT (Ex: Contracts, FTE, ...) |
|
Please add here the required envelop needed to work on the strategize phase - if needed (maximum 40k€) :
What skills and talents do we need?
Here kind of skills required in order to start to fill the Capacity Planning. If name already available please write the name
| AWS, network, security, DSDS, R&I services (LabPCs, simulation), OSS support., Open labs, Agilab / LIMS |
1.12. Methodology to apply (refer for Accolade)
Do you think your initiative will best cope with a waterfall or agile methodology?
|
If the initiative will be done in Agile methodology, please contact during the strategize phase Nicolas LOVAGNINI
Understand: How this bring value? Which pain points will it removes? Will it be delivered in Agile or Waterfall?
|
|
Now, we can move on to the Solution space
Prometheus - DT Infra Project:
What is your list of scope if waterfall initiatives (technical, functional & organizational) / deliverables foreseen? What are your list of Epics if Agile initiatives?
Deploy Research scientist PC applications.
2.1. Actions to complete
| Mandatory actions * (please contact them together if possible) | ||
|---|---|---|
Description of the action / task | Contact | Document & examples (please make your own copy and insert new link here) |
Contact each relevant pool lead to book resources in the capacity planning tool
| Complete Capacity planning tool | |
Complete Accolade
| Claire Bazin | Complete Accolade |
Review with Enterprise Architect the actual solution answering the objective
| Françoise BERGAME @Francois Garang (Structure) | Complete Architecture Impact Analysis (AIA) |
Check you have confirmed the involvement of each platform | Revert to SDM of each Platform | |
Identify security needs (Confidentiality, Integrity, Availability) and define security measures to be implemented by the initiative team
| Complete the security questionnaire in “SIP Support tool” | |
Support for budget estimation (via the Workload & Cost), Financial evaluation (Total Cost of Ownership over 10Y), saving validation
| W&C: to be filled in to Accolade in preparation phase TCO over 10Y: | |
Data Governance: if data is required, please identify the business objects in each domain (refer to envision phase)
|
| |
| Optional | ||
If any relation needed with a supplier
| ||
If it concerns a key supplier, a sourcing strategy has to be defined
| ||
If conformity by design is required
| GMP (pharma), ISO | |
What do users dislike about the current solution?
Applicable when a new solution is developed
LAB PCs are not on Solvay network and data are not preserved/utilized properly.
Researchers cannot work or in very degraded mode
What tools or features do your users wish to have?
| LIMS, Openlabs, Agilab, Geneious, FlowJo, JMP, Daitaiku, Gitlab, Quantum HPC, Pyzo (python), etc... |
What value will it add to the user´s lives?
| Mandatory project as part of an Acquisition. The proposed project will integrate the newly acquired lab in to solvay standards and Researchers will be able to utilize the Solvay standard applications / systems to continue with their Bio mettc research activities. |
What alternative do we have?
| N/A |
A standardised process for creating and introducing services. It may sound basic, but Service Design and Introduction should be considered at the very beginning of the project.
Who is the service owner?
P Vignon +Mark K / J Mijajlovic |
What is the target?
Integration of this new site into Solvay standards.
|
Which platform will maintain the new service?
What are the risks (refer to Risk analysis matrix in Accolade)?
Are there any internal / external constraints and what are the preventive actions associated?
Identify risks and mitigation plans
| Budget must be available to procure Solvay licences for the LAB PC applications by June. Procurement delays can cause legal breach with license used (90 days grace period agreed by the seller). Site Facility contacts must be identified to plan the Cabling, Physical security and facilities related activities. |
What is the qualitative assessment of Hardware/ Data processing/ Project’s contribution to Solvay One Planet?
- Is the business ambition you will support improving or not sustainability? Yes - Will you increase or decrease the number of hardware we need to operate? How much ? Increase in number of Lab PCs and user PCs - Will you generate or transfer an important amount of data, especially videos? How much? No Video, large AWS data (2TB) -Fundamental project to accelerate the transition of Solvay’s portfolio towards a less carbon footprint and more circular portfolio through the use of renewable materials and the biotechnology, requesting an important level of process & data management as well as specific modeling capabilities |